Skip to content
For laboratory research use only · Not for human or veterinary use · Qualified buyers only
Learn

HPLC vs Mass Spectrometry for Peptide Lot Review

HPLC and mass spectrometry answer different questions in peptide lot review: relative purity versus molecular identity. Neither result replaces the other.

HPLC vs Mass Spectrometry for Peptide Lot Review

High-performance liquid chromatography (HPLC) and mass spectrometry (MS) are often mentioned together on a peptide certificate of analysis. They are complementary tools. They do not measure the same thing, and one result should not be treated as a substitute for the other.

Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only.

Two questions, not one headline

In routine lot review, HPLC is commonly used to address relative purity: how the main peak compares with other peaks under a stated method. Mass spectrometry is commonly used to address molecular identity: whether the observed mass is consistent with the named analyte. Those answers can both be necessary. Neither one, by itself, is a complete material file.

A purity percentage does not identify the molecule. A mass that is consistent with the target sequence does not tell you the relative amount of that species in the sample, and it does not state the net content of a vial. How to Read a Peptide COA explains why a purity headline should not be converted into vial content.

What to look for in an HPLC record

A useful HPLC record names the method and shows the trace, not only a number. Conditions, detection, and the sample identifier should be complete enough that a reviewer can see what was actually measured. If the method is missing, or if only a cropped snapshot is supplied, the file is incomplete even if the percentage looks familiar.

Compare the sample identifier on the chromatogram with the identifier on the rest of the report and with the lot on the quotation. A clean-looking trace that cannot be tied to the offered lot does not close the review.

What to look for in a mass-spectrometry record

A useful identity record should be suited to the analyte and should be connected to the same sample story. The report should make clear what was measured and under what identification criteria. A statement that “MS confirms identity,” without a method or a sample identifier, is a claim to follow up, not a finished result.

If the experimental question depends on a specific form — for example, a copper complex rather than the peptide alone — ask whether the identity method actually addresses that form. For that documentation issue in a catalog context, see What Is GHK-Cu? Identity, Copper Complex, and Laboratory Documentation.

Reading both results in one lot file

Complementary questions in a peptide lot review
Tool Typical question Does not, by itself, answer
HPLC (as commonly used for purity) Relative peak purity under a stated method. Molecular identity, or net content of a vial.
Mass spectrometry (as commonly used for identity) Whether observed mass data are consistent with the named analyte. Relative purity, or net content of a vial.
A content or assay result Quantity, when reported with units and a method. The other two questions above.

If one of these records is missing, say so in the file rather than inferring it from the others. Third-Party Peptide Testing, Explained discusses who issued the work and how to connect a sample to a lot. What Is a COA? provides a short definition of the document type.

When you review catalog materials, apply the same split between identity and purity, including on the GHK-Cu, MOTS-c, and NAD+ specification pages. Linked reports are in the COA Library. Other catalog items appear in the product directory.

Using method results in a procurement decision

When two suppliers both provide “HPLC and MS,” do not treat the phrases as equal. Compare the actual method scope, the completeness of the traces or data, and the sample-to-lot identifiers. A shorter report that is fully identified can be more useful than a longer report that cannot be tied to the goods on the quotation.

If your protocol depends on content as well as identity and relative purity, say so in the brief. Ask whether a content or assay result is available, with units. If it is not, record that as an open item rather than calculating one from a purity percentage.

Method questions that remain after you read the report belong in a dated request to the supplier or the issuing laboratory. Specific questions are easier to answer and easier to file than a general request to “send more testing.”

Store the HPLC and MS records with the quotation and the receiving note, not in a separate inbox thread that will be hard to find later. A method result that cannot be retrieved with the lot is of limited use when a later shipment needs to be compared.

Sourcing notes for qualified buyers

Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.

Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.

Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.

My inquiry listNo products added yet0